Skip to main content

Korro Bio, Inc.

KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001703647

In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Korro Bio, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of KRRO: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders9188−3
Shares19.6M18.6M−937.3K (−4.8%)
Value$193.9M$130.4M−$63.5M (−32.8%)

New holders (9)

Institutions that held Korro Bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to KRRO in Q3 2021
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP81,652$576.0K0.06%
Susquehanna Fundamental Investments, LLC46,769$330.0K0.01%
Eversept Partners, LP30,000$211.8K0.02%
HRT Financial LP27,433$193.0K0.00%
ExodusPoint Capital Management, LP26,490$187.0K0.00%
EMC Capital Management27,029$170.0K0.09%
SG Americas Securities, LLC21,851$154.0K0.00%
Franklin Resources Inc10,347$73.0K0.00%
The PNC Financial Services Group, Inc.88$1.00K0.00%

Sold out (12)

Institutions that held Korro Bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of KRRO in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Sphera Funds Management Ltd.275,160$2.74M
Millennium Management LLC188,802$1.88M
Ikarian Capital, LLC69,879$696.0K
Baker Bros. Advisors LP55,555$553.0K
TRB Advisors LP47,285$471.0K
Manufacturers Life Insurance Company, The19,773$197.0K
Squarepoint Ops LLC10,900$109.0K
Victory Capital Management Inc10,450$104.0K
Russell Investments Group, Ltd.7,402$73.0K
Parisi Gray Wealth Management702$7.00K
FNY Investment Advisers, LLC250$2.00K
Advisory Services Network, LLC100$1.00K